Does ashwagandha in zero-proof drinks actually work?
Ashwagandha (Withania somnifera) has solid clinical evidence for reducing cortisol and perceived stress — but the key phrase is 'at clinical doses.' Most studies use 300–600mg of standardised extract (typically KSM-66 or Sensoril), taken consistently over 8–12 weeks. A typical zero-proof drink containing 50–150mg of ashwagandha extract will not produce a measurable acute effect after a single serving. The chronic micro-dosing question is more interesting and genuinely open.
The active compounds in ashwagandha are withanolides — a class of steroidal lactones named after the plant. KSM-66 (root extract, 5% withanolides by HPLC) is the most clinically validated extract, with published RCTs showing statistically significant cortisol reduction (by 27% vs placebo in Chandrasekhar et al. 2012), thyroid hormone modulation, and improvements in VO2 max in athletes. Sensoril (root + leaf extract) has a different withanolide profile and is typically used at lower doses (125–250mg).
The drinks industry challenge: withanolides are bitter and poorly soluble in water. Masking the bitterness requires either very low concentrations (which reduce any potential efficacy) or flavour profiles that work with the bitterness — dark chocolate, coffee, tart berry. The sub-threshold dosing problem is real: if a drink contains 50mg of KSM-66 and you need 300mg for effects, you'd need to drink 6 servings — which would mean consuming substantial sugar and calories alongside any supposed cortisol benefit.
The honest picture: ashwagandha in drinks is more of a positioning ingredient than a functional ingredient at current industry dosing levels. However, the 2023–2024 trend toward higher-dose functional beverages (Recess Mood, Brez, Cann's higher-cannabinoid products) suggests the industry is moving toward dosing levels where effects might become real. A daily 300mg-ashwagandha NA drink consumed consistently for 8 weeks is a genuinely interesting proposition that no one has properly validated in a beverage context yet.
| Dose | Clinical evidence | Typical drink dose | Gap |
|---|---|---|---|
| 300mg/day × 8 weeks | Cortisol ↓27%, stress scores ↓ (RCT) | 50–150mg/serving | 2–6× below minimum effective dose |
| 600mg/day × 8 weeks | Cortisol ↓30%, anxiety ↓ (multiple RCTs) | 50–150mg/serving | 4–12× below minimum effective dose |
| 125mg Sensoril × 60 days | Stress biomarkers ↓ (smaller RCT) | 50–150mg/serving | Near clinical range for some studies |
The zeroproof.one glossary has detailed entries on ashwagandha, KSM-66, adaptogens, and how to read efficacy claims on functional drink labels.